基于黑色素受试者眼底照片自动筛查糖尿病视网膜病变的人工智能软件评估。

IF 2.3 2区医学 Q2 OPHTHALMOLOGY

Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2025-02-01 DOI:10.1097/IAE.0000000000004310

Soda Mbaye, Aïssatou Aw, El Hadji Malick Sy, Aly Mbara Ka, Jean Pierre Diagne, Hawo Madina Diallo, Audrey Samra, Papa Amadou Ndiaye

{"title":"基于黑色素受试者眼底照片自动筛查糖尿病视网膜病变的人工智能软件评估。","authors":"Soda Mbaye, Aïssatou Aw, El Hadji Malick Sy, Aly Mbara Ka, Jean Pierre Diagne, Hawo Madina Diallo, Audrey Samra, Papa Amadou Ndiaye","doi":"10.1097/IAE.0000000000004310","DOIUrl":null,"url":null,"abstract":"Purpose: To assess the Gaiha Prio Retino +™ Artificial Intelligence (AI) software for detecting diabetic retinopathy (DR).Methods: This prospective study was conducted from March 1, 2021, to September 30, 2022, in the Ophthalmology Department of the Abass NDAO Hospital (Dakar, Senegal). The clinical classification of DR was based on American Academy of Ophthalmology. The clinical results were compared with those obtained from the automated reading of retinophotos taken using Gaiha Prio Retino +™, a software designed to detect DR.Results: The study covered 305 eyes. Referable DR was observed in 104 eyes by the ophthalmologist and in 96 eyes by AI, corresponding with a sensitivity of 92.31%, a specificity of 99%, and an area under the curve of 0.989. Vision-threatening DR was detected in 102 eyes by the ophthalmologist and in 94 eyes by AI, with a corresponding sensitivity of 92.16%, specificity of 99.01%, and an area under the curve of 0.975. Maculopathy was identified in 93 eyes by the ophthalmologist and in 89 eyes by AI, with a corresponding sensitivity of 95.7%, specificity of 97.17%, and an area under the curve of 0.988.Conclusion: Considering these results, the authors may conclude that Gaiha Prio Retino +™ is an effective tool for screening referable DR.","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":"330-334"},"PeriodicalIF":2.3000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ASSESSMENT OF ARTIFICIAL INTELLIGENCE SOFTWARE FOR AUTOMATIC SCREENING OF DIABETIC RETINOPATHY BASED ON FUNDUS PHOTOGRAPHS IN MELANODERM SUBJECTS.\",\"authors\":\"Soda Mbaye, Aïssatou Aw, El Hadji Malick Sy, Aly Mbara Ka, Jean Pierre Diagne, Hawo Madina Diallo, Audrey Samra, Papa Amadou Ndiaye\",\"doi\":\"10.1097/IAE.0000000000004310\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: To assess the Gaiha Prio Retino +™ Artificial Intelligence (AI) software for detecting diabetic retinopathy (DR).Methods: This prospective study was conducted from March 1, 2021, to September 30, 2022, in the Ophthalmology Department of the Abass NDAO Hospital (Dakar, Senegal). The clinical classification of DR was based on American Academy of Ophthalmology. The clinical results were compared with those obtained from the automated reading of retinophotos taken using Gaiha Prio Retino +™, a software designed to detect DR.Results: The study covered 305 eyes. Referable DR was observed in 104 eyes by the ophthalmologist and in 96 eyes by AI, corresponding with a sensitivity of 92.31%, a specificity of 99%, and an area under the curve of 0.989. Vision-threatening DR was detected in 102 eyes by the ophthalmologist and in 94 eyes by AI, with a corresponding sensitivity of 92.16%, specificity of 99.01%, and an area under the curve of 0.975. Maculopathy was identified in 93 eyes by the ophthalmologist and in 89 eyes by AI, with a corresponding sensitivity of 95.7%, specificity of 97.17%, and an area under the curve of 0.988.Conclusion: Considering these results, the authors may conclude that Gaiha Prio Retino +™ is an effective tool for screening referable DR.\",\"PeriodicalId\":54486,\"journal\":{\"name\":\"Retina-The Journal of Retinal and Vitreous Diseases\",\"volume\":\" \",\"pages\":\"330-334\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Retina-The Journal of Retinal and Vitreous Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/IAE.0000000000004310\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004310","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

目的：评估用于检测糖尿病视网膜病变（DR）的 Gaiha Prio Retino +™ 人工智能（AI）软件：这项前瞻性研究于 2021 年 3 月 1 日至 2022 年 9 月 30 日在塞内加尔达喀尔 Abass NDAO 医院眼科进行。DR 的临床分类以美国眼科学会的分类为基础。临床结果与使用 Gaiha Prio Retino +™ 自动读取视网膜照片获得的结果进行了比较：研究覆盖了 305 只眼睛。眼科医生发现 104 只眼睛存在可转诊的 DR，人工智能发现 96 只眼睛存在可转诊的 DR，灵敏度为 92.31%，特异度为 99%，曲线下面积 (AUC) 为 0.989。眼科医生检测出 102 只眼睛存在视力危及的 DR，人工智能检测出 94 只眼睛存在视力危及的 DR，灵敏度为 92.16%，特异性为 99.01%，曲线下面积（AUC）为 0.975。眼科医生在 93 只眼睛中发现了黄斑病变，人工智能在 89 只眼睛中发现了黄斑病变，相应的灵敏度为 95.7%，特异性为 97.17%，AUC 为 0.988：综上所述，我们可以得出结论：Gaiha Prio Retino +™ 是筛查可转诊 DR 的有效工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

ASSESSMENT OF ARTIFICIAL INTELLIGENCE SOFTWARE FOR AUTOMATIC SCREENING OF DIABETIC RETINOPATHY BASED ON FUNDUS PHOTOGRAPHS IN MELANODERM SUBJECTS.

Purpose: To assess the Gaiha Prio Retino +™ Artificial Intelligence (AI) software for detecting diabetic retinopathy (DR).

Methods: This prospective study was conducted from March 1, 2021, to September 30, 2022, in the Ophthalmology Department of the Abass NDAO Hospital (Dakar, Senegal). The clinical classification of DR was based on American Academy of Ophthalmology. The clinical results were compared with those obtained from the automated reading of retinophotos taken using Gaiha Prio Retino +™, a software designed to detect DR.

Results: The study covered 305 eyes. Referable DR was observed in 104 eyes by the ophthalmologist and in 96 eyes by AI, corresponding with a sensitivity of 92.31%, a specificity of 99%, and an area under the curve of 0.989. Vision-threatening DR was detected in 102 eyes by the ophthalmologist and in 94 eyes by AI, with a corresponding sensitivity of 92.16%, specificity of 99.01%, and an area under the curve of 0.975. Maculopathy was identified in 93 eyes by the ophthalmologist and in 89 eyes by AI, with a corresponding sensitivity of 95.7%, specificity of 97.17%, and an area under the curve of 0.988.

Conclusion: Considering these results, the authors may conclude that Gaiha Prio Retino +™ is an effective tool for screening referable DR.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Retina-The Journal of Retinal and Vitreous Diseases 医学-眼科学

CiteScore

5.70

自引率

9.10%

发文量

554

审稿时长

3-6 weeks

期刊介绍： RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice. In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color. Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.